Ruth Frances Keir runs Cambridge Cognition (AIM: COG), one of the 10 Com­pa­nies to Watch in 2013/ 2014 accord­ing to our lat­est mar­ket report, which develops and commercializes computerised neuropsychological tests used in a variety of healthcare and research settings. She joined the Cambridge Cognition board initially in 2010 as a non-executive director, bringing to it more than 26 years’ experience in research and business development positions in the pharmaceutical industry, as well as a period as Director of her own consultancy business, Archea Ltd.

–> To Learn More and Register, click on 2013 Sharp­Brains Vir­tual Sum­mit: Sep­tem­ber 19-20th, 2013